Reaction
Neuropathic Arthropathy reporting signals
As of the last recalculation, Neuropathic Arthropathy appears in 635 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 152.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Canagliflozin | 114 | 152.0 | 152.6 |
| Insulin Human | 37 | 32.3 | 32.4 |
| Human Insulin | 11 | 29.4 | 29.4 |
| Insulin Lispro | 87 | 23.8 | 23.8 |
| Insulin Aspart | 36 | 18.9 | 18.9 |
| Insulin Glargine | 110 | 17.5 | 17.5 |
| Inclisiran | 4 | 16.4 | 16.5 |
| Insulin Degludec | 11 | 15.6 | 15.6 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 8.7 | 8.7 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 6 | 6.4 | 6.4 |